ImmunityBio, Inc 10-K for FY2025
ImmunityBio, Inc. (IBRX)
10-K
2026-02-23
For: 2025-12-31
View Original
Added on
April 10, 2026
About this 10-K
ImmunityBio, Inc filed this 10-K on February 23, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $113.29M
- up 668.3% from $14.75M a year earlier
- Net loss
- $351.4M
- compared with a net loss of $413.56M a year earlier
- Diluted EPS
- -$0.38
- compared with -$0.62 a year earlier